BrainsWay® Deep Transcranial Magnetic Stimulation (Deep TMS) is a FDA-cleared, noninvasive therapy that uses gentle magnetic pulses to stimulate key areas of the brain responsible for mood
regulation. Unlike traditional medications, Deep TMS directly targets the neural pathways linked to depression and obsessive-compulsive disorder (OCD), helping patients experience significant symptom relief—even when other treatments haven’t worked.
How Deep TMS Works for Treatment-Resistant Depression
During each 20-minute session, patients sit comfortably while a specialized helmet delivers targeted magnetic pulses to specific brain regions. There is no anesthesia, no systemic side effects, and no downtime—you can return to work or daily activities immediately afterward.
BrainsWay’s H-coil technology reaches deeper and broader areas of the brain than standard TMS devices, offering a more effective and efficient treatment experience.
FDA approved indications:
TMS therapy is FDA-cleared for depression and continues to be studied for additional mental health conditions
Check out this great video
Research suggests approximately 50% to 60% of people with treatment-resistant depression experience a clinically meaningful response to TMS treatment and 50% experience remission. Clinical results shows even more improvements with 81% response and 65% remission.
TMS for depression is also a great option if experience side effects common to prescription medications.

Please reach us at info@njpremierpsych.com if you cannot find an answer to your question.
Transcranial Magnetic Stimulation (TMS) is a non-invasive, FDA-cleared treatment for depression that uses magnetic pulses to stimulate areas of the brain involved in mood regulation.
At iChange Wellness Center, we use advanced protocols (H1 and H7 coils) to restore healthy brain activity and improve mood, focus, and energy.
TMS may be right for you if:
Patients with moderate to severe symptoms (PHQ-9 ≥ 15) often benefit the most.
Most patients start to feel improvement within 2–3 weeks.

Some patients benefit from Spravato therapy for treatment-resistant depression.